DOI QR코드

DOI QR Code

Development of an In Vitro Pigmented Skin Model to Evaluate the Effectiveness of Whitening Functional Cosmetic Ingredients

미백 기능성 화장품 원료의 유효성 평가를 위한 In Vitro 색소화피부모델 개발

  • 김설영 ((주)바이오솔루션 부설연구소) ;
  • 이건희 ((주)바이오솔루션 부설연구소) ;
  • 곽은지 ((주)바이오솔루션 부설연구소) ;
  • 김수지 ((주)바이오솔루션 부설연구소) ;
  • 이수현 ((주)바이오솔루션 부설연구소) ;
  • 임경민 (이화여자대학교 약학대학)
  • Received : 2021.11.12
  • Accepted : 2021.12.24
  • Published : 2021.12.30

Abstract

In this study, we prepared a pigmented skin model, KeraSkin-MTM for the in vitro evaluation of whitening agents. For the purpose of complementing the existing mono-layer cell culture testing method, KeraSkin-MTM was produced through the co-culture of human skin-derived keratinocytes and melanocytes. The efficacy of four well-known whitening agents (arbutin, ascorbic acid, kojic acid, niacinamide) was evaluated in KeraSkin-MTM in order to assess its usefulness in assessing whitening efficacy. As a result, it was possible to observe additional details such as the distribution of melanin granules and melanin capping in each skin layer through KeraSkin-MTM, which was previously difficult to assess in the traditional 2D cell culture system. In addition, quantification through image analysis of KeraSkin-MTM allowed for a statistical analysis of the whitening effects. These results suggest that the KeraSkin-MTM can be used as a new evaluation method of evaluating whitening efficacy, as well as complement the traditional total melanin content and tyrosinase inhibition assays.

본 연구에서는 미백 기능성 화장품 및 원료의 효능을 평가하는 동물대체시험법을 개발하기 위하여 세포수준과 색소화피부모델(KeraSkin-MTM)에서 기존에 잘 알려진 4종의 미백기능성원료(arbutin, ascorbic acid, kojic acid, niacinamide)의 효능을 평가하였다. 특히 기존 시험법의 보완을 위해 인체피부유래 케라틴세포와 멜라닌세포를 혼합하고 공배양하여 색소화피부모델을 제작하였다. 그 결과 색소화피부모델을 이용하여 미백효능을 평가함으로써 세포수준에서는 확인이 어려웠던 각 피부세포층에 따른 멜라닌 과립과 멜라닌캡(melanin cap)의 분포 등의 지표들을 추가로 확인할 수 있었으며 이미지분석을 통한 정량화로 음성대조군 대비 통계적 유의성을 확인할 수 있었다. 이러한 결과는 KeraSkin-MTM을 이용한 미백효능평가법이 기존에 사용하던 총멜라닌함량와 타이로시나아제 저해 평가를 보완할 수 있는 새로운 평가법으로 사용할 수 있음을 시사한다.

Keywords

Acknowledgement

본 연구는 한국보건산업진흥원의 피부과학 응용소재·선도기술개발 연구과제(과제번호: HP20C0061020021)로 진행되었습니다.

References

  1. S. M. Shin, H. M. Cho, M. H. Kim, T. E. Kim and Y. W. Shin, 2020 Cosmetic industry analysis report. KHIDI, Korea, 1 (2020).
  2. E. J. Seo, E. S. Hong, M. H. Choi, K. S. Kim and S. J. Lee, The antioxidant and skin whitening effect of Artemisia iwayomogi extracts, Korean J. Food Sci. Technol., 44(1), 89 (2012). https://doi.org/10.9721/KJFST.2012.44.1.089
  3. H. J. Kim, H. R. Choi, D. S. Kim and K. C. Park, Topical hypopigmenting agents for pigmentary disorders and their mechanisms of action, Ann. Dermatol., 24(1), 1 (2012). https://doi.org/10.5021/ad.2012.24.1.1
  4. P. Aroca, K. Urabe, T. Kobayashi, K. Tsukamoto, and V. J. Hearing, Melanin biosynthesis patterns following hormonal stimulation, J. Biol. Chem., 268(34), 25650(1993). https://doi.org/10.1016/S0021-9258(19)74439-1
  5. B. A. Kim, Inhibitory effects of fractions from Glycine soja Siebold et Zucc. on melanogenesis in B16F10 melanoma cells, J. Soc. Cosmet. Sci. Korea, 43(3), 231 (2017). https://doi.org/10.15230/SCSK.2017.43.3.231
  6. Y. S. Song, B. Y. Chung, W. G. Cho and S. H. Kang, Development of polyethoxylated ascorbic acid as a whitening agent, J. Soc. Cosmet. Sci. Korea, 26(1), 199 (2000).
  7. J. Thingne s, T. J. Lavelle , E. Hovig and S. W. Omholt, Understanding the melanocyte distribution in human epidermis: An agent-based computational model approach, PoLS One. 7(7), e40377 (2012). https://doi.org/10.1371/journal.pone.0040377
  8. S. W. Jung, N. K. Lee, S. J. kim and D. S. Han, Screening of tyrosinase inhibitor from plants, Korean J. Food Sci. Technol., 27(6), 891 (1995).
  9. J. Y. Kim, M. K. Lee, B. S. Hwang, G. C. Kim and I. G. Hwang, Antioxidant activity and tyrosinase inhibitory activities of Codonopsis lanceolata extract and solvent fraction, Korean J. Food Nutr., 32(6), 611 (2019).
  10. Y. U. Jeong, H. Lee, H. N. Park, K. M. Kim, S. Y. Kim, and Y. J. Park, Studies on antioxidant, anti-inflammation and tyrosinase inhibitory activities of Melissa officinalis extracts and their fractions, J. Soc. Cosmet. Sci. Korea, 44(4), 465 (2018). https://doi.org/10.15230/SCSK.2018.44.4.465
  11. W. Qian, W. Liu, D. Zhu, Y. Cao, A. Tang, G. Gong and H. Su, Natural skinwhitening compounds for the treatment of melanogenesis (review), Exp. Ther. Med., 20(1), 173 (2020). https://doi.org/10.3892/etm.2020.8687
  12. M. G. Choung, Y. S. Hwang, G. P. Kim, K. G. Ahn, H. S. Shim, S. B. Hong, J. H. Choi, C. Y. Yu, I. M. Chung, S. H. Kim and J. D. Lim, Antimelanogenic effect and whitening of anthocyanin rich fraction from seeds of Liriope platyphylla, Korean J. Medicinal Crop Sci. 21(5), 361 (2013). https://doi.org/10.7783/KJMCS.2013.21.5.361
  13. J. M. Gillbro and M. J. Olsson, The me lanoge ne sis and mechanisms of skin-lightening agents - existing and new approaches, Int. J. Cosmet. Sci., 33(3), 210 (2011). https://doi.org/10.1111/j.1468-2494.2010.00616.x
  14. W. Russel and R. Burch, The principles of humane experimental technique, 238, Methuen, London UK (1959).
  15. P. Flecknell, Replacement, reduction and refinement, ALTEX. 19(2), 73 (2002).
  16. V. Rogiers, E. Benfenati, U. Bernauer, L. Bodin, P. Carmichael, Q. Chaudhry, P. J. Coenraads, M. T. D. Cronin, M. Dent, M. Dusinska, C. Ellison, J. Ezendam, E. Gaffet, C. L. Galli, C. Goebel, B. Granum, H. M. Hollnagel, P. S. Kern, K. Kosemund-Meynen, G. Ouedraogo, E. Panteri, C. Rousselle, M. Stepnik, T. Vanhaecke, N. Goetz and A. Worth. The way forward for assessing the human health safety of cosmetics in the EU - Workshop proceedings, Toxicology, Luxembourg, 436 152421 (2020).